SEC Form 4 · accession 0001127602-18-008402
UNITED THERAPEUTICS Corp · UTHR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Benkowitz
Officer — President and COO
Period of report
Feb 21, 2018
Accepted (ET)
Feb 26, 2018 · 4:11 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001082554
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | holding | — | — | — | 1,292 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock OptionsF2,F3 | $146.03 | Feb 21, 2018 | A | 42,940 | A | Mar 15, 2018 | Mar 15, 2027 | Common Stock | 42,940 | 42,940 | D |
Explanation of responses
- F1Includes 204 shares acquired on March 3, 2017 under the United Therapeutics Corporation Employee Stock Purchase Plan ("ESPP").
- F2These performance-based stock options were initially awarded on March 15, 2017, subject to a one-year performance condition tied to company-wide milestone performance for 2017, which was determined on February 21, 2018. Number of stock options reported represents the number of options earned based on milestone performance.
- F3These stock options vest in one-third increments on each of March 15, 2018, 2019 and 2020.